{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,8,25]],"date-time":"2023-08-25T14:47:32Z","timestamp":1692974852715},"reference-count":29,"publisher":"Spandidos Publications","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.3892\/etm.2013.1190","type":"journal-article","created":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T12:20:07Z","timestamp":1372681207000},"page":"819-825","source":"Crossref","is-referenced-by-count":4,"title":["Comparison of cilostazol versus ticlopidine following coronary stenting in patients with coronary heart disease: A meta-analysis of randomized controlled trials"],"prefix":"10.3892","volume":"6","author":[{"given":"FENG-HUAN","family":"HU","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"XIN","family":"YI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YUE-JING","family":"YANG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"SHU-BIN","family":"QIAO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YONG-JIAN","family":"WU","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JIAN-SONG","family":"YUAN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2013,7,1]]},"reference":[{"key":"key20180108131721_b1-etm-06-03-0819","first-page":"382","article-title":"The intercept and slope of breathlessness\/chest pain-heart rate relationship in patients with coronary artery disease using exercise tolerance test","volume":"62","author":"Fatima","year":"2012","journal-title":"J Pak Med Assoc"},{"key":"key20180108131721_b2-etm-06-03-0819","first-page":"38","article-title":"Progress in genetic and epigenetic research on in-stent restenosis after percutaneous coronary interventions","volume":"29","author":"Kang","year":"2012","journal-title":"Zhonghua Yi Xue Yi Chuan Xue Za Zhi"},{"key":"key20180108131721_b3-etm-06-03-0819","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1097\/01.fjc.0000167012.82930.8f","article-title":"RACTS: a prospective randomized antiplatelet trial of cilostazol versus ticlopidine in patients undergoing coronary stenting: long-term clinical and angiographic outcome","volume":"46","author":"Ge","year":"2005","journal-title":"J Cardiovasc Pharmacol"},{"key":"key20180108131721_b4-etm-06-03-0819","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.ahj.2005.06.021","article-title":"Cilostazol improves long-term outcomes after coronary stent implantation","volume":"150","author":"Han","year":"2005","journal-title":"Am Heart J"},{"key":"key20180108131721_b5-etm-06-03-0819","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1536\/jhj.42.43","article-title":"Comparison of ticlopidine and cilostazol for the prevention of restenosis after percutaneous transluminal coronary angioplasty","volume":"42","author":"Nagaoka","year":"2001","journal-title":"Jpn Heart J"},{"key":"key20180108131721_b6-etm-06-03-0819","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1023\/B:CARD.0000033642.49162.04","article-title":"Comparison of cilostazol and ticlopidine for one-month effectiveness and safety after elective coronary stenting","volume":"18","author":"Hashiguchi","year":"2004","journal-title":"Cardiovasc Drugs Ther"},{"key":"key20180108131721_b7-etm-06-03-0819","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/00001573-200109000-00007","article-title":"Adjunctive pharmacotherapy for coronary stenting","volume":"16","author":"Harding","year":"2001","journal-title":"Curr Opin Cardiol"},{"key":"key20180108131721_b8-etm-06-03-0819","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0167-5273(01)00388-6","article-title":"Effect of cilostazol on restenosis after coronary angioplasty and stenting in comparison to conventional coronary artery stenting with ticlopidine","volume":"78","author":"Tanabe","year":"2001","journal-title":"Int J Cardiol"},{"key":"key20180108131721_b9-etm-06-03-0819","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1159\/000339238","article-title":"A meta-analysis of randomized controlled trials appraising the efficacy and safety of cilostazol after coronary artery stent implantation","volume":"122","author":"Jang","year":"2012","journal-title":"Cardiology"},{"key":"key20180108131721_b10-etm-06-03-0819","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jns.2011.09.038","article-title":"Cilostazol combined with aspirin prevents early neurological deterioration in patients with acute ischemic stroke: a pilot study","volume":"313","author":"Nakamura","year":"2012","journal-title":"J Neurol Sci"},{"key":"key20180108131721_b11-etm-06-03-0819","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/S0002-9149(00)01408-9","article-title":"Combination therapy with aspirin plus clopidogrel versus aspirin plus ticlopidine for prevention of subacute thrombosis after successful native coronary stenting","volume":"87","author":"Dangas","year":"2001","journal-title":"Am J Cardiol"},{"key":"key20180108131721_b12-etm-06-03-0819","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1345\/aph.1Q765","article-title":"Use of cilostazol in percutaneous coronary interventions","volume":"46","author":"Rogers","year":"2012","journal-title":"Ann Pharmacother"},{"key":"key20180108131721_b13-etm-06-03-0819","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1159\/000338812","article-title":"Cilostazol-based triple antiplatelet therapy compared to dual antiplatelet therapy in patients with coronary stent implantation: a meta-analysis of 5,821 patients","volume":"122","author":"Geng","year":"2012","journal-title":"Cardiology"},{"key":"key20180108131721_b14-etm-06-03-0819","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1253\/circj.68.610","article-title":"Effects of antiplatelet agents on subacute thrombosis and restenosis after successful coronary stenting: a randomized comparison of ticlopidine and cilostazol","volume":"68","author":"Sekiguchi","year":"2004","journal-title":"Circ J"},{"key":"key20180108131721_b15-etm-06-03-0819","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1093\/ptj\/83.8.713","article-title":"Reliability of the PEDro scale for rating quality of randomized controlled trials","volume":"83","author":"Maher","year":"2003","journal-title":"Phys Ther"},{"key":"key20180108131721_b16-etm-06-03-0819","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat Med"},{"key":"key20180108131721_b17-etm-06-03-0819","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/gepi.20048","article-title":"Heterogeneity testing in meta-analysis of genome searches","volume":"28","author":"Zintzaras","year":"2005","journal-title":"Genet Epidemiol"},{"key":"key20180108131721_b18-etm-06-03-0819","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1001\/jama.295.6.676","article-title":"Comparison of two methods to detect publication bias in meta-analysis","volume":"295","author":"Peters","year":"2006","journal-title":"JAMA"},{"key":"key20180108131721_b19-etm-06-03-0819","first-page":"170","article-title":"A randomized trial of cilostazol versus ticlopidine for anti-platelet therapy after coronary artery stenting for prevention of restenosis","volume":"14","author":"Hong","year":"2006","journal-title":"Chin J Intervent Cardiol"},{"key":"key20180108131721_b20-etm-06-03-0819","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1016\/j.jacc.2004.06.066","article-title":"Cilostazol inhibits leukocyte integrin Mac-1, leading to a potential reduction in restenosis after coronary stent implantation","volume":"44","author":"Inoue","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"key20180108131721_b21-etm-06-03-0819","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1067\/mhj.2002.122874","article-title":"Randomized comparison of cilostazol versus ticlopidine hydrochloride for antiplatelet therapy after coronary stent implantation for prevention of late restenosis","volume":"144","author":"Kamishirado","year":"2002","journal-title":"Am Heart J"},{"key":"key20180108131721_b22-etm-06-03-0819","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1067\/mhj.2001.111548","article-title":"Effects of cilostazol on late lumen loss and repeat revascularization after Palmaz-Schatz coronary stent implantation","volume":"141","author":"Kozuma","year":"2001","journal-title":"Am Heart J"},{"key":"key20180108131721_b23-etm-06-03-0819","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S0002-9149(00)01001-8","article-title":"Effects of cilostazol on angiographic restenosis after coronary stent placement","volume":"86","author":"Park","year":"2000","journal-title":"Am J Cardiol"},{"key":"key20180108131721_b24-etm-06-03-0819","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1253\/circj.69.780","article-title":"Randomized comparison of cilostazol vs ticlopidine for antiplatelet therapy after coronary stenting","volume":"69","author":"Takeyasu","year":"2005","journal-title":"Circ J"},{"key":"key20180108131721_b25-etm-06-03-0819","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/S0002-9149(99)00579-2","article-title":"Usefulness of cilostazol versus ticlopidine in coronary artery stenting","volume":"84","author":"Yoon","year":"1999","journal-title":"Am J Cardiol"},{"key":"key20180108131721_b26-etm-06-03-0819","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1177\/0091270009338940","article-title":"Addition of cilostazol to aspirin and a thienopyridine for prevention of restenosis after coronary artery stenting: a meta-analysis","volume":"50","author":"Jennings","year":"2010","journal-title":"J Clin Pharmacol"},{"key":"key20180108131721_b27-etm-06-03-0819","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1159\/000086918","article-title":"Meta-analysis of trials comparing oral anticoagulation and aspirin versus dual antiplatelet therapy after coronary stenting. Clues for the management of patients with an indication for long-term anticoagulation undergoing coronary stenting","volume":"104","author":"Rubboli","year":"2005","journal-title":"Cardiology"},{"key":"key20180108131721_b28-etm-06-03-0819","first-page":"CD002133","article-title":"Ticlopidine versus oral anticoagulation for coronary stenting","author":"Cosmi","year":"2001","journal-title":"Cochrane Database Syst Rev"},{"key":"key20180108131721_b29-etm-06-03-0819","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/j.ahj.2004.03.066","article-title":"Cilostazol, clopidogrel or ticlopidine to prevent sub-acute stent thrombosis: a meta-analysis of randomized trials","volume":"148","author":"Schleinitz","year":"2004","journal-title":"Am Heart J"}],"container-title":["Experimental and Therapeutic Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/etm.2013.1190\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,29]],"date-time":"2020-07-29T12:09:23Z","timestamp":1596024563000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/etm.2013.1190"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7,1]]},"references-count":29,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2013,7,1]]},"published-print":{"date-parts":[[2013,9]]}},"alternative-id":["10.3892\/etm.2013.1190"],"URL":"https:\/\/doi.org\/10.3892\/etm.2013.1190","relation":{},"ISSN":["1792-0981","1792-1015"],"issn-type":[{"value":"1792-0981","type":"print"},{"value":"1792-1015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,7,1]]}}}